Trials / Completed
CompletedNCT01567345
Intrathecal Morphine Administration Using Implantable Pump With Continuous or Programmable Flow
Comparison of Two Types of Intrathecal Morphine Administration by Pump for Analgesia in Cancer Patients With Failure of Conventional Analgesic Therapy.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Institut Cancerologie de l'Ouest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to compare intrathecal morphine administration: using a pump with continuous or programmable flow.
Detailed description
Cancer is frequently associated with pain. In spite of recent improvements in cancer related pain treatment, incidence of cancerous chronic pain did not decrease. Indeed, 15 to 20% of patients are still suffering from intractable pain despite an optimal symptom management. Treatment of cancer pain is generally based on the WHO analgesic ladder according to 3 steps. Patients with advanced cancer are often treated at WHO step 3 analgesics, i.e. morphine and its derivatives, at high dosages. But increasing the dosage of opioids also leads to accentuation of their adverse events and the corresponding risks. At this stage of the disease, in patients with failure of conventional analgesic therapy, intrathecal injection of analgesics can be decided in order to relieve pain. 2 types of pumps allow intrathecal morphine administration : continuous or programmable flow. In this study, we want to compare the quality of analgesia obtained through these 2 flows.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantable pump with continuous flow | Insertion of an implantable pump filled up with the analgesic solution. Connection of the catheter to the intrathecal space. Continuous morphine's flow is scheduled. |
| DEVICE | Implantable pump with programmable flow. | Insertion of an implantable pump filled up with the analgesic solution. Connection of the catheter to the intrathecal space. Programmable morphine's flow is scheduled. |
Timeline
- Start date
- 2009-01-14
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2012-03-30
- Last updated
- 2024-08-02
Locations
6 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01567345. Inclusion in this directory is not an endorsement.